Regulus Therapeutics Inc (NASDAQ:RGLS)

During the Trading Day
13.45 -0.02 / -0.15%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.45 0.00 / 0.00%
Volume: 6.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 1
Quarter 2
Quarter 3
Quarter 4
Revenue and IncomeNet Revenues1.6M736.0K1.1M4.2M
Depreciation And Amortization354.0K346.0K398.0K392.0K
Operating ExpensesGross Income----------
General Expenses12.0M13.4M12.3M13.4M
Research And Development9.6M10.8M10.2M10.5M
Total Operating Expenses12.3M13.7M12.7M13.8M
Non-Operating ExpensesOperating Income-10.7M-13.0M-11.7M-9.5M
Extraordinary Credit0.00953.0K1.8M--
Extraordinary Charge-2.1M0.00---12.7M
Interest Expense On Debt11.0K10.0K10.0K8.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.7M-12.0M-9.8M-22.2M
Income Taxes-1.0K0.000.000.00
Net Income-12.7M-12.0M-9.8M-22.2M
Shares To Calculate EPSShares To Calculate EPS42.7M43.4M43.4M46.9M
Shares To Calculate EPS Diluted42.7M44.8M43.4M46.9M
Earnings Per ShareEPS-$0.30-$0.29-$0.23-$0.47
EPS Diluted-$0.30-$0.29-$0.23-$0.47

To view my watchlist

Not a member yet?

Sign up now for a free account